Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. The company is headquartered in Rahway, New Jersey and currently employs 75,000 full-time employees. Its Pharmaceutical segment includes human health pharmaceutical and vaccine products. The firm sells its human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers. The company sells these human health vaccines primarily to physicians, wholesalers, distributors and government entities. Its Animal Health segment discovers, develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all livestock and companion animal species. Its products include KEYTRUDA (pembrolizumab) injection, for intravenous use; WELIREG (belzutifan) tablets, for oral use; Ohtuvayre (ensifentrine) and others.
Mr. Robert Davis est le Chairman of the Board de Merck & Co Inc, il a rejoint l'entreprise depuis 2014.
Quelle est la performance du prix de l'action MRK ?
Le prix actuel de MRK est de $116.67, il a augmenté de 0.25% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de Merck & Co Inc ?
Merck & Co Inc appartient à l'industrie Pharmaceuticals et le secteur est Health Care
Quel est la capitalisation boursière de Merck & Co Inc ?
La capitalisation boursière actuelle de Merck & Co Inc est de $288.4B
Est-ce que Merck & Co Inc est un achat, une vente ou un maintien ?
Selon les analystes de Wall Street, 30 analystes ont établi des notations d'analystes pour Merck & Co Inc, y compris 7 achat fort, 12 achat, 14 maintien, 0 vente et 7 vente forte